Diagnostic company SphingoTec announces that in the consensus statement of the 28 th ADQI workgroup, penKid is recognized as a relevant functional biomarker able to predict SA-AKI with high accuracy.
Diagnostic company SphingoTec announces that in the consensus statement of the 28 th ADQI workgroup, penKid is recognized as a relevant functional biomarker able to predict SA-AKI with high accuracy.